BioCentury
ARTICLE | Clinical News

Telcyta: Phase III resumed

June 25, 2007 7:00 AM UTC

FDA converted the full clinical hold on Telcyta to a partial hold, which will allow TELK to continue to treat patients who are already enrolled in the Phase III ASSIST-3 and ASSIST-5 trials to treat o...